Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01513070Phase 4Completed
Phase 4, randomised, double-blind trial of Suxiao Jiuxin Pills in angina pectoris and coronary stenosis (2 arms), sponsored by Guang'anmen Hospital. Primary endpoint: Effective power of angina pectoris at 6 months. Started Apr 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01513070.